COMMUNIQUÉS West-GlobeNewswire

INNATE PHARMA : Nouveau nombre d'actions et de droits de vote d'Innate Pharma au 1er novembre 2018
08/11/2018
nouveau NOMBRE D'ACTIONS ET DE DROITS DE VOTE d'InnatE Pharma AU 1 er novembre 2018 Marseille, le 8 novembre 2018, 7h00 CET Conformément aux articles L. 233-8 II du Code de Commerce et 223-16 du règlement général de l' [...]
Kiadis Pharma strengthens core team with three senior appointments
08/11/2018
Amsterdam, The Netherlands, November 8, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS) , a clinical-stage biopharmaceutical company, today announces that it has [...]
Amphastar Pharmaceuticals, Inc. Announces Reintroduction of Primatene® MIST
08/11/2018
Primatene ® MIST fills unmet medical need as the only FDA approved over-the-counter asthma inhaler RANCHO CUCAMONGA, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) announced [...]
Vital Therapies Announces Third Quarter 2018 Financial Results
08/11/2018
SAN DIEGO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL), a biotherapeutic company that has been developing ELAD ® , a cell-based therapy targeting the treatment of acute forms of liver failure, [...]
Precision Optics Corporation Schedules First Quarter Conference Call
07/11/2018
GARDNER, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the “Company”) today announced that it intends to release its financial results for the fiscal year 2019 first quarter [...]
New England Journal of Medicine publishes positive detailed results from Praluent® (alirocumab) cardiovascular outcomes trial
07/11/2018
New England Journal of Medicine publishes positive detailed results from Praluent ® (alirocumab) cardiovascular outcomes trial Praluent significantly reduced major adverse cardiovascular events by 15% (p<0.001) [...]
Le New England Journal of Medicine publie les résultats positifs détaillés de l'essai clinique consacré à l'effet du Praluent® (alirocumab) sur le risque d'événements cardiovasculaires
07/11/2018
Le New England Journal of Medicine publie les résultats positifs détaillés de l'essai clinique consacré à l'effet du Praluent ® (alirocumab) sur le risque d'événements cardiovasculaires Praluent a significativement [...]
Entasis Therapeutics Announces Zoliflodacin Phase 2 Results Published in The New England Journal of Medicine
07/11/2018
Zoliflodacin Was Well-Tolerated and Successfully Treated Substantially All Uncomplicated Gonorrhea Cases Phase 3 clinical trial, in partnership with GARDP, to begin in 2019 WALTHAM, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE [...]
BioTelemetry, Inc. Elects Stephan Rietiker to its Board of Directors
07/11/2018
MALVERN, Pa., Nov. 07, 2018 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) announced today that Stephan Rietiker has been elected to BioTelemetry’s Board of Directors. Dr. Rietiker was most recently the Chief [...]
Neon Therapeutics Appoints Industry Veteran Robert Bazemore to its Board of Directors
07/11/2018
Seasoned executive brings more than 20 years of biopharmaceutical industry experience CAMBRIDGE, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company [...]
Supernus to Present at Three November Healthcare Conferences
07/11/2018
ROCKVILLE, Md., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2018 Financial Results
07/11/2018
-Initiated Phase 1/2 Clinical Trial of CTX001 in β-thalassemia- -Targeting Initiation of Clinical Trial for CTX110, Targeting CD19+ Malignancies, in 1H 2019- -$487.3 Million in Cash as of September 30, 2018- ZUG, [...]
Verrica Pharmaceuticals Reports Third Quarter 2018 Financial Results
07/11/2018
WEST CHESTER, Pa., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical [...]
Geron to Present at Upcoming Investor Conferences in November
07/11/2018
MENLO PARK, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present a company overview at [...]
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
07/11/2018
CRESTWOOD, Ky. and WALTHAM Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
Retrophin to Present at the Jefferies 2018 London Healthcare Conference
07/11/2018
SAN DIEGO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that Stephen Aselage, chief executive officer, will present at the Jefferies 2018 London Healthcare Conference in London, UK on [...]
University of Tübingen Names CureVac Co-Founder & Supervisory Board Chairman, Ingmar Hoerr, Honorary Senator
07/11/2018
TÜBINGEN, Germany and BOSTON, Nov. 07, 2018 (GLOBE NEWSWIRE) -- CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, congratulates CureVac co-founder and Chairman of the [...]
Zosano Pharma to Host Conference Call on Third Quarter 2018 Financial Results and Provide Operational Update
07/11/2018
FREMONT, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN) (“Zosano” or the “Company”), a clinical-stage biopharmaceutical company, today announced that it will host a conference call and [...]
Clearside Biomedical to Participate in Stifel 2018 Healthcare Conference
07/11/2018
ALPHARETTA, Ga., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]

Pages